Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

29. September 2014 10:35 ET | Quelle: Vitae Pharmaceuticals, Inc.

Vitae Pharmaceuticals Announces Closing of Initial Public Offering

FORT WASHINGTON, Pa., Sept. 29, 2014 (GLOBE NEWSWIRE) -- Vitae Pharmaceuticals, Inc. (Nasdaq:VTAE), a clinical stage biotechnology company, today announced the closing of its initial public offering...
24. September 2014 09:25 ET | Quelle: Vitae Pharmaceuticals, Inc.

Vitae Pharmaceuticals Announces Pricing of Initial Public Offering

FORT WASHINGTON, Pa., Sept. 24, 2014 (GLOBE NEWSWIRE) -- Vitae Pharmaceuticals, Inc., a clinical stage biotechnology company, today announced the pricing of its initial public offering of 6,875,000...
08. Juli 2014 08:00 ET | Quelle: Vitae Pharmaceuticals, Inc.

Vitae Pharmaceuticals Adds to Leadership Team With Appointment of Arthur Fratamico as Chief Business Officer, Richard Morris as Chief Financial Officer

FORT WASHINGTON, Pa., July 8, 2014 (GLOBE NEWSWIRE) -- Vitae Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on discovering and developing small molecule drugs, today announced...

Vorherige Seite